BE-80-2100411

Trial medication for thromboembolic disorders

18 - 55
  • Male
  • Female
December - January
< 7 days
max 9
max € 2000

Are you:

  • a healty male or femal (sterilized, menopausal or had hysterectomy) 
  • aged from 18 to 55 jaar (inclusive)
  • with a BMI from 18.0m² to 32.5 kg/m²
  • non-smoker or no more than 5 cigarettes per week 
  • not using daily medication 

What does the trial involve

SGS trial BE-80-2100411 investigated the treatment of thromboembolic disorders, including deep vein thrombosis and pulmonary emboli (blocked blood vessels by blood clots).

During max. 28 weeks you will have the following appointments:

  • a screening visit
  • 4-day (3-night) stay
  • max. 9 short follow-up visits
  • a final examination 

Take part in this trial and

  • help us develop tomorrow's medicines
  • and receive a generous tax-free (in Belgium) payment of max. 
    € 2000

View information leaflet

Any other questions?

Ask your question 

BE-80-2100411

Registration form

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Any other questions?

Ask your question